MedTrace Logo

Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia

NCT00917540 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 495

Last updated 2013-04-09

No results posted yet for this study

Summary

The purpose of the present study is to develop a biological prognostic index in patients with Binet stage A Chronic Lymphocytic Leukemia (CLL) who do not necessitate therapy according to NCI guidelines and to prospectively validate the proposed score system based on the absence/presence of 1, 2 or 3 unfavorable prognostic markers such as cluster of differentiation 38 (CD38) expression, Zap-70 expression and immunoglobulin heavy chain variable region (IgVH) configuration.

Conditions

  • Chronic Lymphocytic Leukemia Stage A(0)
  • Chronic Lymphocytic Leukemia Stage A(I)
  • Chronic Lymphocytic Leukemia Stage A(II)

Sponsors & Collaborators

  • Gruppo Italiano Studio Linfomi

    lead OTHER

Principal Investigators

  • Fortunato Morabito, MD · GISL

  • Manlio Ferrarini, MD · GISL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Completion
2013-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00917540 on ClinicalTrials.gov